Racial differences in bone response to calcitriol therapy in ESKD patients.

被引：0
|
作者：
Sawaya, BP [1 ]
Faugere, MCM [1 ]
Friedler, RM [1 ]
Malluche, HH [1 ]
机构：
[1] Univ Kentucky, Div Nephrol Bone & Mineral Metab Med, Lexington, KY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：202A / 202A
页数：1
相关论文
共 50 条
  • [21] THE PREVALENCE OF BONE ALUMINUM DEPOSITION IN RENAL OSTEODYSTROPHY AND ITS RELATION TO THE RESPONSE TO CALCITRIOL THERAPY
    OTT, SM
    MALONEY, NA
    COBURN, JW
    ALFREY, AC
    SHERRARD, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (12): : 709 - 713
  • [22] Effect of oral calcitriol pulse therapy on bone in hemodialysis patients with renal hyperparathyroidism
    Sperschneider, H
    Humbsch, K
    Abendroth, K
    MEDIZINISCHE KLINIK, 1997, 92 (10) : 597 - 603
  • [23] NEED FOR CALCITRIOL IN PATIENTS WITH APLASTIC BONE
    SHERRARD, DJ
    SEMINARS IN DIALYSIS, 1994, 7 (03) : 220 - 220
  • [24] DEVELOPMENT OF ADYNAMIC BONE IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM AFTER INTERMITTENT CALCITRIOL THERAPY
    GOODMAN, WG
    RAMIREZ, JA
    BELIN, TR
    CHON, Y
    GALES, B
    SEGRE, GV
    SALUSKY, IB
    KIDNEY INTERNATIONAL, 1994, 46 (04) : 1160 - 1166
  • [25] Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
    Clemmer, John S.
    Pruett, W. Andrew
    Lirette, Seth T.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [26] Racial differences in response to glaucoma medications in ocular hypertensive patients
    Bennett, GR
    Cioffi, GA
    Dorr, D
    Gordon, M
    Beck, A
    Fechtner, R
    Kass, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1291 - 1291
  • [27] Are There Any Racial and Ethnic Differences in Response to Medicines in Japanese Patients?
    Nakagawa, Yoshihisa
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (06) : 550 - 552
  • [28] Prediction of radiation therapy response in breast cancer patients.
    Arora, Divya
    Hasan, Salman
    Jebakumar, Deborah
    Munoz, Yolanda
    Ford, John
    Ord, Celine
    Rao, Arundhati
    Deb, Niloyjyoti
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Rabinovich, MB
    Walton, T
    PHARMACOTHERAPY, 2005, 25 (10): : 1465 - 1465
  • [30] Response to bortezomib (BOR) and bone metabolism in multiple myeloma patients.
    Zangari, M
    Esseltine, DL
    Najarian, K
    Elice, F
    Lee, CK
    Yaccoby, S
    Thertulien, R
    Barlogie, B
    Tricot, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 569S - 569S
12345